Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT03559595
NCT03559595CompletedNot Applicable

Increasing Pre-exposure Prophylaxis Among High-Risk African Americans in Louisville KY

University of Louisville1 site in 1 country205 target enrollmentStarted: June 4, 2018Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
205
Locations
1
Primary Endpoint
PrEP uptake
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study evaluates the effectiveness of a multifaceted strategy to increase pre-exposure prophylaxis (PrEP; a medication regimen to reduce HIV risk) uptake among high risk African Americans in Louisville, KY. We will do this by 1) implementing a media campaign to raise awareness about PrEP, 2) providing PrEP education to medical personnel who can prescribe PrEP, and 3) partnering with AIDS service organizations to improve outreach and linkage to PrEP services.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 29 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Between ages 18-29 years old
  • •Self-identifies as African American or Black
  • •Resident of Louisville, KY
  • •Member of a priority group for PrEP HIV prevention (Men who have sex with men, people who inject drugs, trans women, high risk heterosexuals, people in serodiscordant relationships).
  • •Not diagnosed with HIV

Exclusion Criteria

  • •Older than 29 and younger than 18 years old
  • •Does not identify as African American or Black
  • •Does not reside in Louisville, KY
  • •Not a member of a priority group
  • •Diagnosed with HIV

Arms & Interventions

Intervention group

Experimental

All study participants will be exposed to the intervention

Intervention: Project Prevent (Behavioral)

Outcomes

Primary Outcomes

PrEP uptake

Time Frame: 12 months

Reported use of PrEP

Secondary Outcomes

  • PrEP intentions(12 months)
  • PrEP prescription(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jelani Kerr

Assistant Professor

University of Louisville

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese MenHIV Infections
NCT03422172ViiV Healthcare48
Completed
Not Applicable
HIV Pre-exposure Prophylaxis Implementation Hong Kong StudyHIV Infections
NCT04367688Chinese University of Hong Kong339
Completed
Not Applicable
PrEP for Prevention of HIV Transmission Among People Who Inject Drugs in Nairobi, KenyaPrEP UptakeHIV Antibody Positivity
NCT05465265University of Washington256
Completed
Phase 1
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, AfricaHIV Infection
NCT00931346International AIDS Vaccine Initiative72
Completed
Not Applicable
PC4PrEP: Integrating PrEP Into Primary CareHuman Immunodeficiency Virus Transmission
NCT03617874Albert Einstein College of Medicine22